Antitumoral Activity of the Novel BTK Inhibitor TG-1701 is Associated with Disruption of Ikaros Signaling and Improvement of Anti-CD20 Therapy in B-cell Non-Hodgkin Lymphoma

Drug Category : Array
Conference Category : Array
Lead Author : Roue G, et al.
Published Date : 18/06/2021
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2021/06/ICML21-Poster-TG-1701-Preclinical-Roue-FINAL-PDF-6.18.21.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top